John Lyftogt MD
Background and Training
Dr John Lyftogt (pronounced "Liftoff") was born in the Netherlands and graduated from Leiden University Medical faculty in 1973. In 1975 he moved to Christchurch, New Zealand and established a Family Medicine practice. He always had an interest in Sports Medicine and chronic injuries and he undertook post graduate training in Musculoskeletal Medicine.
Dr John Lyftogt has published seven papers and is co-author of an RCT on the treatment of Achilles tendinosis, which was published in The British Journal of Sports Medicine in June 2009 and reprinted in April 2011.
Development of Lyftogt Perineural Injection Treatment ® (previously known as Neural Prolotherapy)
In 2003 he was trained in Adelaide, Australia in traditional Prolotherapy (which uses glucose injections to treat painful conditions) by Dr Margaret Taylor. From this knowledge base he developed a new treatment which he named Neural Prolotherapy (NPT) but is now known as Lyftogt Perineural Injection Treatment™ (Lyftogt P.I.T®).
The results of this treatment were so positive that soon his General Practice became flooded with patients with pain and injuries, both sporting and occupational. He moved to Active Health, a large multi-disciplinary practice at the QEII Sports Stadium in Christchurch, New Zealand, where he further developed the treatment. He moved several times following the devastating 2011 earthquake in Christchurch which destroyed QEII stadium, continuing to treat up to 20 patients per day until late in 2013 when he made the decision to cease active clinical work and focus on teaching this extraordinary treatment to other like-minded health professionals around the world.
Dr John Lyftogt and his wife Maria organised the first Lyftogt Perineural Injection Treatment teaching event in Christchurch in November 2009. Since then, over 2000 health professionals from about 30 countries have attended Dr Lyftogt's educational events in New Zealand, Argentina, Australia, Canada, Egypt, Germany, Italy, the Netherlands, the Philippines, South Korea, Taiwan, Turkey, Mexico and the USA.